Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tolerability of New Formulation Rebif vs Betaseron in RRMS
NCT00428584Phase 3Completed
- Sponsor
- EMD Serono
- Start
- Dec 2006
- Primary completion
- Nov 2007
- Modality
- Cytokines & Interferons
- Countries
- 1
01
Overview
A Phase 3 trial of interferon beta in relapsing-remitting multiple sclerosis (RRMS), sponsored by EMD Serono. Started Dec 2006; status: completed.
02
Drugs
interferon beta
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT00428584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00428584.